Biotech Values

[mcbio]

That wasn’t clear to me when I posted the ENTA valuation model in September. It is now, which is why I’m planning to revise it.

Fair enough.

I encourage you and anyone else to post what you think the US/EU blended pricing number in the model ought to be. Please bear in mind that I’m looking for the real-world price (net of discounts and rebates), not the list price.

For me personally, I want to see the real-world prices for Olysio and Sovaldi in combo with peg/riba before I wager a good guess on pricing of ABBV/ENTA 3-DAA combo.